Toker cells revisited

Breast Journal

Volumn 15, Issue 4, 2009, Pages 394-398

  Nofech Mozes, Sharon ^a   Hanna, Wedad ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Breast cancer; CK7; HER2 neu; Paget's disease of nipple; Prophylactic mastectomy; Toker cells

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PREVENTION; CELL; CELL HYPERPLASIA; EPIDERMIS; FEMALE; GENE MUTATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; NIPPLE; PAGET NIPPLE DISEASE; PROPHYLACTIC MASTECTOMY; TOKER CELL;

ADULT; AGED; BRCA1 PROTEIN; BREAST NEOPLASMS; CARRIER STATE; FEMALE; HUMANS; KERATIN-7; KERATINOCYTES; MASTECTOMY; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PAGET'S DISEASE, MAMMARY;

EID: 67650730111     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00743.x     Document Type: Article

References (14)

1. Willman JH, Golitz LE, Fitzpatrick JE. Vulvar clear cells of Toker: precursors of extramammary Paget's disease. Am J Dermatopathol 2005 27 : 185 8.
2. Zeng Z, Melamed J, Symmans PJ, et al. Benign proliferative nipple duct lesions frequently contain CAM 5.2 and anti-cytokeratin 7 immunoreactive cells in the overlying epidermis. Am J Surg Pathol 1999 23 : 1349 55.
3. Hoda SA, Chung SM, Gopalan A. Evolving entities and changing concepts in breast pathology. Breast Cancer 2003 10 : 294 300.
4. NCCN. Clinical Practice Guidelines in Oncology, Breast Cancer. National Comprehensive Cancer Network, Inc, 2007 [cited 2007 Dec 17] 80 1.
5. Toker C. Clear cells of the nipple epidermis. Cancer 1970 25 : 601 10.
6. Lundquist K, Kohler S, Rouse RV. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells. Am J Surg Pathol 1999 23 : 212 9.
7. Marucci G, Betts CM, Golouh R, Peterse JL, Foschini MP, Eusebi V. Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description. Virchows Arch 2002 441 : 117 23.
8. Yao DX, Hoda SA, Chiu A, Ying L, Rosen PP. Intraepidermal cytokeratin 7 immunoreactive cells in the non-neoplastic nipple may represent interepithelial extension of lactiferous duct cells. Histopathology 2002 40 : 230 6.
9. van der Putte SC, Toonstra J, Hennipman A. Mammary Paget's disease confined to the areola and associated with multifocal Toker cell hyperplasia. Am J Dermatopathol 1995 17 : 487 93.
10. Decaussin M, Laville M, Mathevet P, Frappart L. Paget's disease versus Toker cell hyperplasia in a supernumerary nipple. Virchows Arch 1998 432 : 289 91.
11. Hanna W, Alowami S, Malik A. The role of HER-2/neu oncogene and vimentin filaments in the production of the Paget's phenotype. Breast J 2003 9 : 485 90.
12. Morandi L, Pession A, Marucci GL, et al. Intraepidermal cells of Paget's carcinoma of the breast can be genetically different from those of the underlying carcinoma. Hum Pathol 2003 34 : 1321 30.
13. Shousha S. Glandular Paget's disease of the nipple. Histopathology 2007 50 : 812 4.
14. Barnes PJ, Dumont RJ, Higgins HG. Acinar pattern of mammary Paget's disease: a case report. Breast J 2007 13 : 520 6.